Death risk prediction model for patients with non-traumatic intracerebral hemorrhage

非创伤性脑出血患者死亡风险预测模型

阅读:2

Abstract

BACKGROUND: This study aimed to assess the risk of death from non-traumatic intracerebral hemorrhage (ICH) using a machine learning model. METHODS: 1274 ICH patients who met the specified inclusion and exclusion criteria were analyzed retrospectively in the MIMIC IV 3.0 database. Patients were randomly divided into training, validation, and testing datasets in a ratio of 6:2:2 based on the outcome distribution. Data from the Second Hospital of Lanzhou University were used as an external validation set. This study used LASSO regression and multivariable logistic regression analysis to screen for features. We then employed XGBoost to construct a machine-learning model. The model's performance was evaluated using ROC curve analysis, calibration curve analysis, clinical decision curve analysis, sensitivity, specificity, accuracy, and F1 score. Conclusively, the SHapley Additive exPlanations (SHAP) method was employed to interpret the model's predictions. RESULTS: Deaths occurred in 572 out of the 1274 ICH cases included in the study, resulting in an incidence rate of 44.9%. The XGBoost model achieved a high AUC when predicting deaths in ICH patients (train: 0.814, 95%CI: 0.784 - 0.844; validation: 0.715, 95%CI: 0.653 - 0.777; test: 0.797, 95%CI: 0.743 - 0.851). The importance of SHAP variables in the model ranked from high to low was: 'GCS motor', 'Age', 'GCS eyes', 'Low density lipoprotein (LDL)', ' Albumin', ' Atrial fibrillation', and 'Gender'. The XGBoost model demonstrated good predictive performance in both the validation and external validation datasets. CONCLUSIONS: The XGBoost machine learning model we built has demonstrated strong performance in predicting the risk of death from ICH. Furthermore, the SHAP provides the possibility of interpreting machine learning results.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。